Eterna Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $5.79 million. The enterprise value is $52.25 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ERNA has 5.41 million shares outstanding. The number of shares has increased by 27.24% in one year.
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +27.24% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 34.27% |
| Owned by Institutions (%) | 13.41% |
| Float | 3.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.74 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 322.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37
| Current Ratio | 0.37 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -29.41% |
| Return on Capital (ROIC) | -34.49% |
| Revenue Per Employee | $20,250 |
| Profits Per Employee | -$2.99M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.32% in the last 52 weeks. The beta is 7.76, so ERNA's price volatility has been higher than the market average.
| Beta (5Y) | 7.76 |
| 52-Week Price Change | -18.32% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 47.61 |
| Average Volume (20 Days) | 31,486 |
Short Selling Information
The latest short interest is 61,003, so 1.13% of the outstanding shares have been sold short.
| Short Interest | 61,003 |
| Short Previous Month | 54,421 |
| Short % of Shares Out | 1.13% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
In the last 12 months, ERNA had revenue of $162,000 and -$23.94 million in losses. Loss per share was -$4.43.
| Revenue | 162,000 |
| Gross Profit | -180,000 |
| Operating Income | -21.99M |
| Pretax Income | -22.90M |
| Net Income | -23.94M |
| EBITDA | -21.86M |
| EBIT | -21.99M |
| Loss Per Share | -$4.43 |
Full Income StatementBalance Sheet
The company has $2.59 million in cash and $49.21 million in debt, giving a net cash position of -$46.62 million or -$8.62 per share.
| Cash & Cash Equivalents | 2.59M |
| Total Debt | 49.21M |
| Net Cash | -46.62M |
| Net Cash Per Share | -$8.62 |
| Equity (Book Value) | -8.53M |
| Book Value Per Share | -1.58 |
| Working Capital | -6.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.49 million and capital expenditures -$369,000, giving a free cash flow of -$16.86 million.
| Operating Cash Flow | -16.49M |
| Capital Expenditures | -369,000 |
| Free Cash Flow | -16.86M |
| FCF Per Share | -$3.12 |
Full Cash Flow StatementMargins
| Gross Margin | -111.11% |
| Operating Margin | -13,572.84% |
| Pretax Margin | -14,768.52% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -15,845.22% |